Pivhydrazine
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
N'-benzyl-2,2-dimethyl-propanehydrazide
|
|
| Clinical data | |
| Routes of administration |
Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 306-19-4  |
| ATC code | none |
| PubChem | CID 9375 |
| ChemSpider | 9007 |
| ChEMBL | CHEMBL2106941 |
| Synonyms | Angorvid, Betamezid, Neomarsilid, Pivazide, Pivhydrazine |
| Chemical data | |
| Formula | C12H18N2O |
| Molar mass | 206.28 g/mol |
|
|
| (verify) | |
Pivhydrazine (BAN; trade name Tersavid), also known as pivalylbenzhydrazine and pivazide, is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was formerly used as an antidepressant in the 1960s, but has since been discontinued.[1][2][3]
See also[edit]
References[edit]
- ^ Herman, ZS; Sokola, A; Lenartowicz, H; Zieliński, M; Depta, L (May–June 1976). "The influence of antidepressive drugs on the level of acetylcholine and on the acetylcholinesterase activity in the brain of rats". Polish Journal of Pharmacology and Pharmacy. 28 (4): 313–321. ISSN 0301-0244. OCLC 1586290. PMID 981020.
- ^ Bolton, GC; Griffiths, LA (November–December 1979). "The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat". Drug Metabolism and Disposition: the Biological Fate of Chemicals. 7 (6): 388–392. ISSN 0090-9556. OCLC 1784380. PMID 43225. Retrieved 2011-09-15.
- ^ Mikhaĭlova, TV; Gilev, AP; Khavronina-Gureeva, ZP (1969). "[Central effects of betamezide]". Farmakologii︠a︡ i toksikologii︠a︡. (in Russian). 32 (6): 652–656. ISSN 0014-8318. OCLC 1568906. PMID 5381593.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
